Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 1,398,190 shares at $67.70 ($94.5M) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Open-market sale of $94.5M SLNO by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.81 | 106,471 | $7.0M | 7.4% |
| 2 | $65.81 | 106,471 | $7.0M | 7.4% |
| 3 | $65.97 | 14,183 | $936K | 1.0% |
| 4 | $65.97 | 14,183 | $936K | 1.0% |
| 5 | $66.33 | 209,689 | $13.9M | 14.7% |
| 6 | $66.33 | 209,689 |
| $13.9M |
| 14.7% |
| 7 | $66.79 | 23,095 | $1.5M | 1.6% |
| 8 | $66.79 | 23,095 | $1.5M | 1.6% |
| 9 | $67.37 | 8,423 | $567K | 0.6% |
| 10 | $67.37 | 8,423 | $567K | 0.6% |
| 11 | $67.70 | 41,989 | $2.8M | 3.0% |
| 12 | $67.70 | 41,989 | $2.8M | 3.0% |
| 13 | $68.79 | 55,234 | $3.8M | 4.0% |
| 14 | $68.79 | 55,234 | $3.8M | 4.0% |
| 15 | $69.30 | 199,226 | $13.8M | 14.6% |
| 16 | $69.30 | 199,226 | $13.8M | 14.6% |
| 17 | $69.84 | 31,980 | $2.2M | 2.4% |
| 18 | $69.84 | 31,980 | $2.2M | 2.4% |
| 19 | $70.73 | 3,291 | $233K | 0.2% |
| 20 | $70.73 | 3,291 | $233K | 0.2% |
| 21 | $71.74 | 4,782 | $343K | 0.4% |
| 22 | $71.74 | 4,782 | $343K | 0.4% |
| 23 | $72.64 | 732 | $53K | 0.1% |
| 24 | $72.64 | 732 | $53K | 0.1% |
| Total | $67.62 avg | 1,398,190 | $94.5M | 100% |
| Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $1.6M | — | Filing → |